What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod?: a discrete choice experiment survey from the SINS trial
Background: The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk nodular and superficial basal cell carcinoma (BCC). The trial included a discre...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
BioMed Central
2012
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/2903/ |